Close
ACHEMA MIDDLE EAST 2026

Drug Delivery Innovation & Peptide-Stabilized Emulsions

A new study which has been led by Prof. Meital Reches from the Hebrew University, along with Mr. Daniel Boas, one of the Ph.D....

New Molecular Device Opens Door To Targeted Drug Delivery

In one of the newly brought up breakthroughs that could go ahead and even revolutionize medical as well as material engineering, scientists have gone...

Lab Bottlenecks? Digitalized Lab Management Systems Can Help

Analytical as well as research laboratories happen to be at the heart of driving scientific breakthroughs in order to address some of the world’s...

Rare Illnesses: mRNA Therapy May Swap Intracellular Proteins

Notably, the interim data from a Phase I/II clinical trial goes on to suggest that mRNA-3927, which happens to be an investigational mRNA therapy...

LAI Antipsychotic – Given The Green Light Across The EU

It is indeed worth noting the fact that the first once-every-two-months long-acting injectable- LAI antipsychotic, given a nod by the European Commission- EC is...

New Advancements – A Game-Changer In Biological Drug Delivery

It is worth noting that the pharmaceutical sector happens to be steadily shifting toward what are known as biologics, or biological drugs. The fact...

Innovation To Propel The Advanced Drug Delivery Sector

One of the reports by Towards Healthcare has gone on to forecast that the advanced drug delivery market is going to value $375.86 billion...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...